• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种快速灵敏的细菌检测法,用于测定“界面”肽对在大肠杆菌中共同表达的HIV-1蛋白酶的抑制作用。

A rapid and sensitive bacterial assay to determine the inhibitory effect of 'interface' peptides on HIV-1 protease co-expressed in Escherichia coli.

作者信息

Ast O, Jentsch K D, Schramm H J, Hunsmann G, Lüke W, Petry H

机构信息

German Primate Centre, Department of Virology and Immunology, Göttingen.

出版信息

J Virol Methods. 1998 Mar;71(1):77-85. doi: 10.1016/s0166-0934(97)00202-4.

DOI:10.1016/s0166-0934(97)00202-4
PMID:9628224
Abstract

The HIV-1 protease is essential for maturation of virus particles and is, therefore, an attractive target for antiviral drugs. The function of this protease depends on the dimerization of two identical subunits. Commonly used protease inhibitors are directed mainly against the active site of the enzyme which often leads to viral resistance. To determine the inhibitory effect of peptides interfering with the dimerization site of the HIV-1 protease, a recombinant bacterial screening assay was established. Escherichia coli was co-transformed with two different plasmids, expressing the 'interface' peptide and an active HIV-1 protease toxic for the bacteria. Co-expression of inhibitory peptides overcomes the incomplete membrane transmission of supplemented inhibitors and leads to a direct interaction of the inhibitory peptide and the HIV-1 protease. The inhibitory effect of co-expressed peptides was measured by an increased growth of co-transformed bacteria, compared with a slowly growing E. coli control culture only expressing the HIV-1 protease. Using this assay several penta- and hexa-peptides were screened for their ability to inhibit HIV-1 protease activity. One of these peptides showed a significant inhibitory effect on co-expressed recombinant HIV-1 protease.

摘要

HIV-1蛋白酶对于病毒颗粒的成熟至关重要,因此是抗病毒药物的一个有吸引力的靶点。这种蛋白酶的功能依赖于两个相同亚基的二聚化。常用的蛋白酶抑制剂主要针对酶的活性位点,这常常导致病毒产生抗性。为了确定干扰HIV-1蛋白酶二聚化位点的肽的抑制作用,建立了一种重组细菌筛选试验。将大肠杆菌用两种不同的质粒共转化,这两种质粒分别表达“界面”肽和对细菌有毒性的活性HIV-1蛋白酶。抑制肽的共表达克服了补充抑制剂不完全的膜转运,并导致抑制肽与HIV-1蛋白酶直接相互作用。与仅表达HIV-1蛋白酶的生长缓慢的大肠杆菌对照培养物相比,通过共转化细菌生长的增加来测量共表达肽的抑制作用。利用该试验筛选了几种五肽和六肽抑制HIV-1蛋白酶活性的能力。其中一种肽对共表达的重组HIV-1蛋白酶显示出显著的抑制作用。

相似文献

1
A rapid and sensitive bacterial assay to determine the inhibitory effect of 'interface' peptides on HIV-1 protease co-expressed in Escherichia coli.一种快速灵敏的细菌检测法,用于测定“界面”肽对在大肠杆菌中共同表达的HIV-1蛋白酶的抑制作用。
J Virol Methods. 1998 Mar;71(1):77-85. doi: 10.1016/s0166-0934(97)00202-4.
2
A rapid and simple screening method for HIV-1 protease inhibitors using recombinant Escherichia coli.一种使用重组大肠杆菌的快速简便的HIV-1蛋白酶抑制剂筛选方法。
J Antibiot (Tokyo). 1994 Apr;47(4):492-5. doi: 10.7164/antibiotics.47.492.
3
Triterpenes as potential dimerization inhibitors of HIV-1 protease.三萜类化合物作为HIV-1蛋白酶潜在的二聚化抑制剂。
Biochem Biophys Res Commun. 1996 Oct 14;227(2):484-8. doi: 10.1006/bbrc.1996.1533.
4
Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.通过在大肠杆菌中抵御活性介导的细胞毒性来筛选HIV蛋白酶抑制剂。
J Virol Methods. 2006 Oct;137(1):82-7. doi: 10.1016/j.jviromet.2006.06.003. Epub 2006 Jul 18.
5
An E. coli expression system which detoxifies the HIV protease.
Biomed Biochim Acta. 1991;50(4-6):643-6.
6
Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.对称的含氟二醇基HIV蛋白酶抑制剂。邻位氟化和间位氟化的P1/P1'-苄氧基侧基显著提高了抗病毒活性并保留了结合效力。
Eur J Biochem. 2004 Nov;271(22):4594-602. doi: 10.1111/j.1432-1033.2004.04431.x.
7
Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.利用匹配的细菌表达载体和前病毒感染载体分析对1型人类免疫缺陷病毒蛋白酶抑制剂的耐药性。
J Virol. 1995 Sep;69(9):5431-6. doi: 10.1128/JVI.69.9.5431-5436.1995.
8
Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.利用在大肠杆菌中高水平表达的纯化野生型和突变融合蛋白对HIV-1蛋白酶进行自加工。
Eur J Biochem. 1991 Jul 15;199(2):361-9. doi: 10.1111/j.1432-1033.1991.tb16132.x.
9
A folding inhibitor of the HIV-1 protease.一种HIV-1蛋白酶的折叠抑制剂。
Proteins. 2006 Mar 1;62(4):928-33. doi: 10.1002/prot.20849.
10
The inhibition of human immunodeficiency virus proteases by 'interface peptides'.
Antiviral Res. 1996 May;30(2-3):155-70. doi: 10.1016/0166-3542(96)00940-0.

引用本文的文献

1
A single mutation in the core domain of the lac repressor reduces leakiness.核心域中单个突变降低 lac 阻遏物的漏读。
Microb Cell Fact. 2013 Jul 8;12:67. doi: 10.1186/1475-2859-12-67.